Due to ethical restrictions imposed by the Ethic Committee of the Medical Faculty of the Christian-Albrechts University of Kiel as well as legal restrictions imposed by German legislation, all data cannot be made publicly available. A minimal dataset is provided as a supplemental file. Further data is available upon request.

Introduction {#sec001}
============

Sarcopenia is a common problem in the Western world. It is characterized by progressive and generalized loss of skeletal muscle mass and strength with the risk of adverse outcomes, such as physical disability, poor quality of life and death \[[@pone.0167124.ref001],[@pone.0167124.ref002]\]. Furthermore, impairment in skeletal muscle function is age-related and associated with a decrease in fiber number and an increase in extramyocyte space \[[@pone.0167124.ref003]\]. The fiber cross-sectional area and amount of connective tissue undergo significant age-related changes \[[@pone.0167124.ref004]\].

Coenzyme Q~10~ (CoQ~10~) plays a crucial role in mitochondrial bioenergetics, including ATP production \[[@pone.0167124.ref005],[@pone.0167124.ref006]\]. Furthermore, CoQ~10~ could act as an antioxidant, preventing oxidative damage of lipids, proteins and DNA \[[@pone.0167124.ref007],[@pone.0167124.ref008]\]. Moreover, CoQ~10~ has been identified as a modulator of gene expression \[[@pone.0167124.ref009], [@pone.0167124.ref010]\] and is necessary for the function of uncoupling proteins \[[@pone.0167124.ref011]\] and pyrimidine biosynthesis \[[@pone.0167124.ref012]\]. The percentage of the oxidized form of CoQ increases with age, indicating a decreased anti-oxidative capacity of aged individuals \[[@pone.0167124.ref013]\]. On the other hand, we have found that the phenotypic characteristics of senescence in SAMP1 mice can be partly counteracted by supplementation with the reduced form of CoQ~10~ \[[@pone.0167124.ref014]\]. Previous reports have documented different contributors to sarcopenia (including TNF-α-dependent apoptotic signaling), which could be potential targets for CoQ~10~. Hence, pro-apoptotic responses to TNF-α are mediated by activation of the plasma membrane neutral sphingomyelin phosphodiesterase (SMPD2) \[[@pone.0167124.ref015]\]. Navas and coworkers have previously demonstrated that SMPD activity is regulated by CoQ through noncompetitive inhibition of the enzyme \[[@pone.0167124.ref016],[@pone.0167124.ref017]\]. Dietary supplementation with CoQ abolished age-related increases of SMPD activity in the rat liver plasma membrane \[[@pone.0167124.ref018]\]. Moreover, it was shown that a higher expression of muscle peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a major factor that controls mitochondrial biogenesis and respiration, protects from sarcopenia during aging \[[@pone.0167124.ref019]\] and that PGC-1α expression was increased in SAMP1 mice by dietary supplementation of reduced CoQ~10~ (ubiquinol) \[[@pone.0167124.ref020]\].

In the present study, we aimed to investigate the determinants of muscular strength with a particular focus on CoQ~10~ in two independent cohorts that compromise a total of n = 1301 subjects. The European Working Group on Sarcopenia in Older People (EWGSOP) has recommended hand grip strength as a robust and simple measure of muscle strength \[[@pone.0167124.ref021]\]. Furthermore, reduced grip strength has been associated with an increased risk of all-cause and cardiovascular mortality and is even a stronger predictor than systolic blood pressure \[[@pone.0167124.ref022],[@pone.0167124.ref023]\]. Thus, in our study, the values for hand grip were correlated with the CoQ~10~ status, age, BMI and peak expiratory flow (PEF) as a measure of respiratory muscle function, which could also be affected in age-associated alterations in skeletal muscles \[[@pone.0167124.ref024]\]. Accordingly, the EWGSOP identified PEF as an alternative measure of muscle strength. To evaluate the influence of the variables that predict the outcome of muscular strength independently, analysis of covariance (ANCOVA) was performed with hand grip as the dependent variable. Because cholesterol is the main transport vehicle for CoQ~10~ in serum \[[@pone.0167124.ref007],[@pone.0167124.ref025]\] and cholesterol and CoQ~10~ share parts of a common synthetic pathway \[[@pone.0167124.ref026]\], the plasma CoQ~10~/cholesterol ratio was used in ANCOVA. Additionally in the basic study population, the muscle mass, creatinine content and creatine kinase activity were determined.

Materials and Methods {#sec002}
=====================

Participants and Ethical Statement {#sec003}
----------------------------------

The basic study population consisted of 334 apparent healthy blood donors and is part of the PopGen control cohort \[[@pone.0167124.ref027],[@pone.0167124.ref028]\]. The validation population (n = 967) is part of the FoCus cohort \[[@pone.0167124.ref029]\]. The participants in this European study collective were recruited in cooperation with the University Hospital Schleswig-Holstein (UKSH), Kiel, Germany as healthy blood donors or in the adiposity ambulance of UKSH. Both populations have been described recently \[[@pone.0167124.ref030]\] and raw data of participants are given in [S1 Table](#pone.0167124.s001){ref-type="supplementary-material"}

The present study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all of the procedures that involve human subjects were approved by the ethics committee of the Medical Faculty of the Christian-Albrechts University of Kiel. All participants gave their written informed consent before participation.

CoQ~10~ and blood parameters {#sec004}
----------------------------

Analysis of ubiquinol-10 and ubiquinone-10 was based on the method of HPLC with electrochemical detection after hexane extraction and has been described before \[[@pone.0167124.ref031]\]. Ubiquinol-9 and ubiquinone-9 were used as internal standards.

Blood samples were taken from every participant after an overnight fast. Serum concentrations of total cholesterol were measured by an enzymatic colorimetric assay (Hitachi Modular; Roche). Creatinine and creatine kinase were analyzed by standard clinical chemistry.

Physiological measurements {#sec005}
--------------------------

Standing height and weight were measured in light clothing without shoes. Body mass index (BMI) was calculated by dividing the weight (kg) by the square of the height (m^2^). Total plasma creatinine values were used to calculate the muscle mass in the basic study population \[[@pone.0167124.ref032],[@pone.0167124.ref033]\]. Beforehand, the plasma volume was determined by using the equation by Sprenger et al. \[[@pone.0167124.ref034]\], which considers the height, weight and hematocrit of the participants.

Upper muscular strength (hand grip strength) was characterized with a digital dynamometer (MAP 80K1, Kern, Balingen, Germany). The participants maintained the standard bipedal position during the entire test with the arm in complete extension. Each participant performed the test three times with each hand. The highest value was chosen as the test score for each hand (dominant and non-dominant hand), and an average score for both hands was computed as the bimanual hand grip score according to \[[@pone.0167124.ref008]\]. Peak flow was measured by having the person exhale as forcefully as possible through the peak flow meter (Mini Wright Standard) after a maximum inspiration.

Statistical analysis {#sec006}
--------------------

Statistical analysis was performed using IBM SPSS 23.0 software (Armonk, New York, USA) and GraphPad Prism 4.0 package (La Jolla, California, USA). The data are expressed as the mean ± SD, and statistical significance was set at p\<0.05. After testing for normality (Kolmogorov-Smirnov), significant differences between sexes were analyzed by a two-sided, unpaired Student's t-test in the case of normally distributed parameters or by the Mann-Whitney-U-Test in the case of non-normally distributed parameters. Correlation analysis (Spearman's or Pearson's correlation, dependent on the distributions of the parameters) was conducted for all of the measured variables in both of the study populations and separately for both genders. Analysis of covariance (ANCOVA) was performed on both cohorts, with "hand grip" as the dependent variable. Gender was taken as an independent factor and BMI, age and CoQ~10~/cholesterol as independent covariates. Prior to ANCOVA, the different terms were controlled for the significance of interaction.

Results {#sec007}
=======

Characterization of the basic study population {#sec008}
----------------------------------------------

The age, body composition (weight, height, BMI, muscle mass), and biochemical profile, including the CoQ~10~ status and functional status (hand grip, peak flow), of the study population, separated by gender, are shown in [Table 1](#pone.0167124.t001){ref-type="table"}. The total study population (n = 178 males, n = 156 females) had a mean age of 40.4 ± 11.2 years (age range 19--61 years), and all of the parameters evaluated were within the normal range, including BMI, total CoQ~10~, CoQ~10~ redox state (% oxidized CoQ~10~ in total), peak flow and hand grip. As expected, men had a significantly higher body weight, height, BMI, muscle mass, peak flow and hand grip compared to females. With regard to the biochemical profile, men also showed higher serum levels of total CoQ~10~, CoQ~10~/cholesterol, creatine kinase and creatinine.

10.1371/journal.pone.0167124.t001

###### Characterization of the basic study population (*n* = 334).

![](pone.0167124.t001){#pone.0167124.t001g}

                                                                       Males (*n* = 178)   Females (*n* = 156)   Total (*n* = 334)                                                                
  -------------------------------------------------------------------- ------------------- --------------------- ------------------------------------------------------- -------- --------------- --------
  **Age (years)**                                                      41.0 ± 10.9         0.008                 39.8 ± 11.5                                             −0.258   40.4 ± 11.2     −0.015
  p = 0.918                                                            **p\<0.01**         p = 0.780                                                                                              
  **Weight (kg)**                                                      87.6 ± 14.7         0.245                 73.1 ± 14.7[\*\*\*](#t001fn006){ref-type="table-fn"}    0.271    80.8 ± 16.4     0.525
  **p\<0.01**                                                          **p\<0.01**         **p\<0.001**                                                                                           
  **Height (cm)**                                                      182.1 ± 7.3         0.207                 168.9 ± 6.75[\*\*\*](#t001fn006){ref-type="table-fn"}   0.242    175.9 ± 9.6     0.672
  **p\<0.01**                                                          **p\<0.01**         **p\<0.001**                                                                                           
  **Muscle mass**[^**b**^](#t001fn003){ref-type="table-fn"} **(kg)**   32.6 ± 5.15         0.172                 19.8 ± 3.92[\*\*\*](#t001fn006){ref-type="table-fn"}    0.306    26.7 ± 7.89     0.744
  **p\<0.05**                                                          **p\<0.001**        **p\<0.001**                                                                                           
  **Peak flow (L/min)**                                                525.3 ± 98.5        0.316                 388.2 ± 55.1[\*\*\*](#t001fn006){ref-type="table-fn"}   0.274    461.3 ± 106.2   0.525
  **p\<0.001**                                                         **p\<0.01**         **p\<0.001**                                                                                           
  **BMI (kg/m**^**2**^**)**                                            26.4 ± 4.08         0.138                 25.6 ±4.79[\*\*](#t001fn005){ref-type="table-fn"}       0.175    26.0 ± 4.4      0.212
  p = 0.067                                                            **p\<0.05**         **p\<0.001**                                                                                           
  **CoQ**~**10**~ **(μg/mL)**                                          0.978 ± 0.37        0.004                 0.872 ± 0.29[\*\*](#t001fn005){ref-type="table-fn"}     -0.099   0.929 ± 0.34    0.103
  p = 0.955                                                            p = 0.217           p = 0.061                                                                                              
  **CoQ**~**10**~ **redox (%)**                                        12.1 ± 2.53         0.073                 12.4 ± 2.20                                             −0.067   12.3 ± 2.4      −0.066
  p = 0.333                                                            p = 0.407           p = 0.232                                                                                              
  **CoQ**~**10**~**/cholesterol (μmol/mol)**                           193.7 ± 53.4        0.004                 177.3 ± 54.1[\*\*](#t001fn005){ref-type="table-fn"}     -0.025   186.0 ± 54.4    0.154
  p = 956                                                              p = 0.756           **p\<0.01**                                                                                            
  **Cholesterol (mmol/L)**                                             5.01 ± 1.03         -0.015                4.91 ± 0.77                                             -0.148   4.96 ± 0.917    0.013
  p = 0.844                                                            p = 0.066           p = 0.812                                                                                              
  **Creatine kinase (U/L)**                                            166.1 ± 94.1        0.013                 106.7 ±62.7[\*\*\*](#t001fn006){ref-type="table-fn"}    0.018    138.4 ± 86.2    0.365
  p = 0.865                                                            p = 0.827           **p\<0.001**                                                                                           
  **Creatinine (mg/dL)**                                               0.904 ± 0.12        0.039                 0.713 ± 0.11[\*\*\*](#t001fn006){ref-type="table-fn"}   0.063    0.815 ±0.151    0.570
  p = 0.604                                                            p = 0.436           **p\<0.001**                                                                                           
  **Hand grip** ~**Dominant\ hand**~ **(kg)**                          52.4 ± 8.63                               32.5 ± 5.88[\*\*\*](#t001fn006){ref-type="table-fn"}             43.1 ± 12.4     

Data are presented as the mean ± SD. BMI: body mass index; CoQ~10~: total Coenzyme Q~10~; CoQ~10~ redox: % oxidized CoQ~10~ in total.

^a^r = Spearman's correlation coefficient between the hand grip and the evaluated parameter in the total study population. In the case of a normal distribution (muscle mass, cholesterol), Pearson's correlation was applied.

^b^Muscle mass was calculated according to \[[@pone.0167124.ref032]--[@pone.0167124.ref034]\].

\*p\<0.05

\*\*p\<0.01

\*\*\*p\<0.001 significant differences between the sexes, evaluated by the Mann-Whitney-U-Test after testing for normality (Kolmogorov-Smirnov). In case of a normal distribution (muscle mass; cholesterol), Student's t-test was applied.

We hypothesized that the selected parameters (as age, BMI and CoQ~10~ status) are determinants of hand grip, a valid proxy of upper-body muscular strength ([Table 1](#pone.0167124.t001){ref-type="table"}, [Fig 1](#pone.0167124.g001){ref-type="fig"}). Correlation analysis of the total study population to hand grip revealed significant positive associations between hand grip and CoQ~10~/cholesterol (r = 0.154, p\<0.01, [Fig 1A](#pone.0167124.g001){ref-type="fig"}), BMI (r = 0.212, p\<0.001, [Fig 1B](#pone.0167124.g001){ref-type="fig"}), peak flow (r = 0.525, p\<0.001, [Fig 1D](#pone.0167124.g001){ref-type="fig"}), creatine kinase (r = 0.365, p\<0.001, [Fig 1E](#pone.0167124.g001){ref-type="fig"}) and creatinine (r = 0.570, p\<0.001, [Fig 1F](#pone.0167124.g001){ref-type="fig"}). The highest correlation coefficient was evident between hand grip and muscle mass (r = 0.744, p\<0.001). No significant association was evident between hand grip and age (r = −0.015, p = 0.780, [Fig 1C](#pone.0167124.g001){ref-type="fig"}), total CoQ~10~ (r = 0.103, p = 0.061), CoQ~10~ redox (r = -0.066, p = 0.232) and total cholesterol (r = 0.013, p = 0.812). Except for the parameters BMI (r = 0.138, p = 0.067) and age (r = 0.008, p = 0.918), which were only significantly correlated to hand grip in females, similar outcomes were found when both genders were correlated separately.

![Scatterplots of correlations between hand grip and CoQ~10~/cholesterol, body mass index, age, peak flow, creatine kinase and creatinine in the basic study population (n = 334).\
Spearman's correlation analysis revealed a significant relationship (p\<0.01) between hand grip and CoQ~10~/cholesterol (A), BMI (B), peak flow (C), creatine kinase (E) and creatinine (F), whereas the correlation between hand grip and age (C) was statistically not significant. Spearman's correlation coefficient (r), p-values and regression lines are given. CoQ~10~: Coenzyme Q~10~; BMI: body mass index.](pone.0167124.g001){#pone.0167124.g001}

Characterization of the validation population {#sec009}
---------------------------------------------

To further evaluate the determinants of muscular strength, we validated our results derived from the basic study population on a second, independent cohort. The characteristics of this validation population are given in [Table 2](#pone.0167124.t002){ref-type="table"}. This population consists of 341 males and 626 females for a total of 967 subjects; they exhibited a mean age of 52.6 ± 14.1 years (age range: 20--85 years). Thus, this population was, on average, 10 years older than the basic study population. Furthermore, among the validation population, 468 obese study subjects (BMI \>30, mean BMI: 40.8 ± 8.52 kg/m^2^) were incorporated to provide a broader BMI range. In total, the population showed a mean BMI of 32.2 ± 10.4 kg/m^2^, which is considered to be obese. The remaining parameters, however, were within the normal range, including the total CoQ~10~,CoQ~10~ redox state (oxidized CoQ~10~ in total) and hand grip. Similarly, males had a significantly higher body weight, height, total CoQ~10~ levels and hand grip and were on average 6 years older than females.

10.1371/journal.pone.0167124.t002

###### Characterization of the validation population (*n* = 967), including 658 overweight/obese study subjects.

![](pone.0167124.t002){#pone.0167124.t002g}

                                                Males (*n* = 341)   Females (*n* = 626)   Total (*n* = 967)                                                                    
  --------------------------------------------- ------------------- --------------------- ------------------------------------------------------- ------------- -------------- --------
  **Age (years)**                               56.1 ± 13.5         -0.427                50.6 ± 14.5[\*\*\*](#t002fn005){ref-type="table-fn"}    -0.416        52.6 ± 14.1    -0.137
  **p\<0.001**                                  **p\<0.001**        **p\<0.001**                                                                                               
  **Weight (kg)**                               102.3 ± 33.2        0.195                 92.6 ± 32.1[\*\*\*](#t002fn005){ref-type="table-fn"}    0.230         96.0 ± 32.8    0.270
  **p\<0.001**                                  **p\<0.001**        **p\<0.001**                                                                                               
  **Height (cm)**                               180.5 ± 8.5         0.331                 168.0 ± 6.7[\*\*\*](#t002fn005){ref-type="table-fn"}    0.434         172.4 ± 9.5    0.695
  **p\<0.001**                                  **p\<0.001**        **p\<0.001**                                                                                               
  **BMI (kg/m**^**2**^**)**                     31.3 ± 9.0          0.115                 32.8 ± 11.0                                             0.131         32.2 ± 10.4    0.056
  **p\<0.05**                                   **p\<0.01**         p = 0.082                                                                                                  
      **BMI \<25 (normal)**                     23.2 ± 1.59         0.301                 22.1 ± 2.07                                             0.170         22.4 ± 2.01    0.170
  (*n* = 88)                                    **p\<0.01**         (*n* = 221)           **p\<0.01**                                             (*n* = 309)   **p\<0.01**    
      **BMI 25--30 (overweight)**               27.3 ± 1.13         −0.144                27.3 ± 1.19                                             −0.110        27.3 ± 1.16    −0.110
  (*n* = 112)                                   p = 0.131           (*n* = 78)            p = 0.131                                               (*n* = 190)   p = 0.131      
      **BMI \>30 (obese)**                      39.4 ± 8.68         -0.044                41.4 ± 8.39                                             0.002         40.8 ± 8.52    0.002
  (*n* = 141)                                   p = 0.601           (*n* = 327)           p = 0.973                                               (*n* = 468)   p = 0.973      
  **CoQ**~**10**~ **(μg/mL)**                   0.852 ± 0.30        -0.071                0.801 ± 0.28[\*\*](#t002fn004){ref-type="table-fn"}     -0.120        0.819 ± 0.29   -0.002
  p = 0.193                                     **p\<0.01**         p = 0.946                                                                                                  
  **CoQ**~**10**~ **redox (%)**                 13.4 ± 2.31         -0.035                13.6 ± 2.08[\*](#t002fn003){ref-type="table-fn"}        -0.059        13.5 ± 2.17    -0.082
  p = 0.525                                     p = 0.143           **p\<0.01**                                                                                                
  **CoQ**~**10**~**/cholesterol (μmol/mol)**    193.1 ± 56.0        -0.088                168.8 ± 49.3[\*\*\*](#t002fn005){ref-type="table-fn"}   -0.029        177.3 ± 53.0   0.131
  p = 0.104                                     p = 0.476           **p\<0.001**                                                                                               
  **Cholesterol (mmol/L)**                      4.41 ± 0.887        0.046                 4.76 ± 0.989                                            -0.207        4.63 ± 0.968   -0.185
  p = 0.393                                     **p\<0.001**        **p\<0.001**                                                                                               
  **Hand grip** ~**Dominant\ hand**~ **(kg)**   42.5 ± 9.4                                25.0 ± 6.4[\*\*\*](#t002fn005){ref-type="table-fn"}                   31.2 ± 11.3    

Data are presented as the mean ± SD. BMI: body mass index; CoQ~10~: total Coenzyme Q~10~; CoQ~10~ redox: % oxidized CoQ~10~ in total.

^a^r = Spearman's correlation coefficient between the hand grip and the evaluated parameter in the total study population. In the case of a normal distribution (cholesterol), Pearson's correlation was applied.

\*p\<0.05

\*\*p\<0.01

\*\*\*p\<0.001 significant differences between the sexes, evaluated by the Mann-Whitney U-Test after testing for normality (Kolmogorov-Smirnov). In the case of a normal distribution (hand grip; cholesterol), Student's t-test was applied.

To substantiate our results in the basic study population, we correlated the parameters that were available with the values of the hand grip measurements ([Table 2](#pone.0167124.t002){ref-type="table"}, [Fig 2](#pone.0167124.g002){ref-type="fig"}). Accordingly, correlation analysis revealed a significant positive association between hand grip and the CoQ~10~/cholesterol ratio (r = 0.131, p\<0.001, [Fig 2A](#pone.0167124.g002){ref-type="fig"}) and a negative significant association to cholesterol itself (r = -0.185, p\<0.001). Hand grip correlated with BMI in the total validation population and revealed no significant relationship (r = 0.056, p = 0.082). However, when we examined the BMI classes separately ([Fig 2B](#pone.0167124.g002){ref-type="fig"}), we found a significant correlation in subjects who exhibited a normal BMI (\<25 kg/m^2^, r = 0.170, p\<0.01), but not in overweight subjects (BMI 25--30 kg/m^2^, r = -0.110, p = 0.131) or obese subjects (BMI \>30, r = 0.002, p\<0.973). Furthermore, hand grip was negatively correlated with age (r = -0.137, p\<0.001, [Fig 2C](#pone.0167124.g002){ref-type="fig"}) and the CoQ~10~ redox state (r = -0.082, p\<0.01, [Fig 2D](#pone.0167124.g002){ref-type="fig"}), which represents a lower percentage of the reduced form of CoQ~10~ (ubiquinol) in subjects who exhibited lower muscular strength. In the validation population, similar outcomes were found when males and females were correlated separately with hand grip, with the exception of total CoQ~10~ (r = -0.071, p = 0.193) and cholesterol (r = -0.046, p = 0.393), which were only significantly correlated in females.

![Scatterplots of correlations between hand grip and CoQ~10~/cholesterol ratio, body mass index, age and CoQ10 redox in the validation population (n = 967).\
Spearman's correlation analysis revealed a significant relationship (p\<0.01) between hand grip and CoQ~10~/cholesterol (A), normal BMI (\<25 kg/m^2^, B), age (C) and CoQ~10~ redox (D). The correlations between hand grip and overweight (BMI 25--30 kg/m^2^) and obese subjects (BMI \>30) were statistically not significant. Spearman's correlation coefficient (r), p-values and regression lines are given. CoQ~10~: Coenzyme Q~10~; CoQ~10~ redox: % oxidized coenzyme Q~10~ in total; BMI: body mass index.](pone.0167124.g002){#pone.0167124.g002}

CoQ~10~ status and muscular strength stratified according to Gender, Age and BMI {#sec010}
--------------------------------------------------------------------------------

To independently evaluate the influence of the variables that predict the outcome of the upper body muscular strength (hand grip) in the basic study population, analysis of covariance (ANCOVA) was performed with hand grip as the dependent variable. In a model, including the gender of the study subjects as the independent factor and CoQ~10~/cholesterol, age and BMI as the independent covariates, gender was found to be the main effector (p\<0.001, partial η^2^ = 0.636, data not shown). Next, we analyzed the remaining variables independent of gender, which revealed a significant effect on hand grip according to BMI (p\<0.05, η^2^ = 0.017), whereas CoQ~10~/cholesterol (p = 0.099) and age (p = 0.563) were not significant predictors of hand grip in this study population ([Table 3A](#pone.0167124.t003){ref-type="table"}).

10.1371/journal.pone.0167124.t003

###### Analysis of covariance (ANCOVA) between hand grip, CoQ~10~/cholesterol ratio, age and BMI in A) the basic study population (n = 334) and B) the validation population (n = 967), including 658 overweight/obese subjects.

![](pone.0167124.t003){#pone.0167124.t003g}

  Source                            Type III sum of Squares                           df   *F*     Significance   Partial η^2^
  --------------------------------- ------------------------------------------------- ---- ------- -------------- --------------
  **A) Basic study population**                                                                                   
  **Corrected Model**               1,477[^**a**^](#t003fn001){ref-type="table-fn"}   3    3.24    0.022          0.029
  **Intercept**                     6491                                              1    42.7    \<0.001        0.115
  **CoQ**~**10**~**/cholesterol**   416                                               1    2.74    0.099          0.008
  **Age**                           50.9                                              1    0.336   0.563          0.001
  **BMI**                           872                                               1    5.74    0.017          0.017
  **B) Validation population**                                                                                    
  **Corrected Model**               4,049[^**b**^](#t003fn002){ref-type="table-fn"}   3    10.8    \<0.001        0.033
  **Intercept**                     28,617                                            1    230.1   \<0.001        0.193
  **CoQ**~**10**~**/cholesterol**   2,266                                             1    18.2    \<0.001        0.019
  **Age**                           2164                                              1    17.4    \<0.001        0.018
  **BMI**                           2.13                                              1    0.017   0.896          \<0.001

**^a^R^2^ = ~0.033~ (Adjusted R^2^ = ~0.030~),** dependent variable: hand grip, independent covariate: age, CoQ~10~/cholesterol, BMI

**^b^R^2^ = ~0.029~ (Adjusted R^2^ = ~0.020~),** dependent variable: hand grip, independent covariate: age, CoQ~10~/cholesterol, BMI

BMI = body mass index; df = degrees of freedom, *F* = variance ratio

Thus, we intended to test our hypothesis in an independent validation study population, which was characterized, on average, by a higher number of subjects, higher mean age and higher mean BMI values. When we analyzed the influence of the variables that predict the outcome of upper body muscular strength (hand grip, dependent factor) in ANCOVA with gender as an independent factor and CoQ~10~/cholesterol and BMI as independent covariates, gender was found to be the strongest effector of hand grip (p\<0.001, η^2^ = 0.601, data not shown). However, when we analyzed the remaining variables independent of gender, we found a significant effect on hand grip by CoQ~10~/cholesterol (p\<0.001, η^2^ = 0.019) and age (p\<0.001, η^2^ = 0.018), whereas in this study population, which is characterized by a higher percentage of obese subjects, BMI was no longer a significant predictor of hand grip (p = 0.896, [Table 3B](#pone.0167124.t003){ref-type="table"}).

Discussion {#sec011}
==========

Aging is associated with sarcopenia, which is a loss of skeletal muscle mass and function \[[@pone.0167124.ref035]\]. CoQ~10~ plays a crucial role in mitochondrial bioenergetics and can act as an antioxidant \[[@pone.0167124.ref007],[@pone.0167124.ref036]\]. However, CoQ~10~ as a determinant of muscular strength is not well documented. Therefore, this study is, to the best of our knowledge, the first to examine the determinants of muscular strength with a special focus on the serum CoQ~10~ status in two independent cohorts. We showed that the CoQ~10~/cholesterol ratio was significantly correlated with a lower hand grip and a predictor of hand grip outcome. Gender was found to be the main influencing factor. Age was also significantly negatively correlated with muscle strength, but only in older subjects (males and females) of the validation population, which exhibited a mean age of 52.6 ± 14.1 years in males or 39.8 ± 11.5 years in females, of the basic study population. Interestingly, the positive association between hand grip and BMI was dependent on the BMI classes because we found a significant correlation in the subjects of the validation population who exhibited a normal BMI, but not in overweight or obese subjects ([Fig 2B](#pone.0167124.g002){ref-type="fig"}). This finding was irrespective of gender. We conclude that in a normal BMI range, an increase in BMI equals an increase in muscle mass, whereas in obese subjects (BMI\>30), an increase in BMI possibly equals an increase in fat mass and hence does not necessarily lead to an increase in muscle strength. In our basic study population, which had a mean BMI of 26.0 ± 4.4, BMI was significantly correlated with hand grip strength ([Fig 1B](#pone.0167124.g001){ref-type="fig"}) and also with muscle mass (r = 0.205, p\<0.001), which agrees with our hypothesis. Similarly, in a population of elderly women, higher BMI values were associated with a greater probability of a functional limitation \[[@pone.0167124.ref037]\]. Here, the isometric leg strength was significantly lower in subjects with sarcopenia and sarcopenic obesity. In an observational cross-sectional study, older men and women with weak muscle strength and higher BMI had considerably poorer performance than others \[[@pone.0167124.ref038]\]. The authors suggested a very likely benefit of early assessment and interventions to reduce fat mass and improve muscle strength in the prevention of future functional limitations.

The relationship of obesity and health and CoQ~10~ as a major lipophilic antioxidant and mitochondrial respiratory chain redox coupler \[[@pone.0167124.ref039]\] is currently a matter of debate. Recently, the impact of aging, BMI and physical capacity on the CoQ~10~ levels in human blood was investigated \[[@pone.0167124.ref008]\]. In a cohort of community-dwelling people (n = 43, mean age = 71.01 ± 6.22 years), the impact of hand grip measurements and further parameters of physical activity on the CoQ~10~ plasma level was studied. The authors found that people who exhibited higher levels of functional capacity presented lower levels of cholesterol, which was accompanied by higher levels of CoQ~10~ in plasma. On the other hand, obesity was related to lower CoQ~10~ levels. They concluded that physical activity at advanced ages can increase the levels of CoQ~10~ and reduce the levels of lipid peroxidation in plasma, probably reducing the progression of cardiovascular diseases. In accordance with these findings, in our validation population, cholesterol itself as well as the CoQ~10~ redox state were significantly negative correlated with hand grip. For the observed lower level of CoQ~10~/cholesterol in the validation population, we cannot fully rule out that it could be partly caused by normalization to the significantly different cholesterol level. Hence, we showed that in this older and obese study group, the subjects who exhibited a lower level of muscular strength presented a higher level of cholesterol and a lower percentage of reduced CoQ~10~ (ubiquinol). In this context, it is worthwhile to mention that physical activity has been shown to generate reactive oxygen species (ROS) \[[@pone.0167124.ref040]\]; however, on the other hand, it has also been demonstrated to be a preventive mechanism against oxidative stress. Different training degrees have been suggested to be beneficial in humans by enhancing the antioxidant capacity \[[@pone.0167124.ref041]\]. Importantly, it has also been shown by Ristow and coworkers \[[@pone.0167124.ref042]\] that dietary antioxidants could counteract the health-promoting effects of physical exercise due to a suppression of endogenous antioxidant defense mechanisms (the so-called "hormesis" effect). In addition to upper body muscular strength (hand grip), we also indicated that peak expiratory flow (PEF) is a function of respiratory muscle, which could also be affected in age-associated alterations in skeletal muscles, which has been shown to be correlated with hand grip strength \[[@pone.0167124.ref024]\]. In a study comprising data from 960 older individuals, pulmonary function was suggested to partially account for the association of muscle strength and mortality \[[@pone.0167124.ref043]\]. In the present study, PEF was also significantly correlated with hand grip strength in the basic study population. Furthermore, when we correlated CoQ~10~/cholesterol versus PEF, a significant Spearman correlation coefficient (r = 0,138, p\<0.05) was evident (data not shown). Similarly, CoQ~10~/cholesterol was significantly correlated with muscle mass (r = 0.1425, p\<0.01).

CoQ~10~ supplementation increases plasma levels of CoQ~10~ \[[@pone.0167124.ref044]--[@pone.0167124.ref046]\]. Nevertheless, short-term dosing of CoQ~10~ in middle-aged, untrained men did not improve the aerobic capacity of forearm exercise metabolism \[[@pone.0167124.ref047]\]. On the other hand, a placebo controlled study with supplementation of 300 mg of ubiquinol for 6 weeks significantly enhanced physical performance, which was measured as the maximum power output in young healthy trained Olympic athletes \[[@pone.0167124.ref048]\]. A systematic review to analyze the influence and effect of CoQ~10~ supplementation on parameters related to exercise in healthy humans revealed that CoQ~10~ has the potential to be used as a nutritional supplement to improve exercise capacity; however, the current literature shows a disparity and inconsistency, possibly due to differences in the CoQ~10~ formulations used, dosage, timing of the supplement, exercise tests performed and study participants \[[@pone.0167124.ref049]\].

In conclusion, the present data suggest that gender and CoQ~10~/cholesterol are determinants of muscular strength, with gender being the main influencing factor. In older subjects, age is an additional inverse determinant of muscular strength, whereas the body mass of a person ascertains muscular strength only when in the normal range. A lower CoQ~10~/cholesterol level could be a predictor of an increased risk of sarcopenia in humans due to its association to upper body muscle strength, peak flow and muscle mass. The present study provides further evidence that a higher muscular strength or physical activity in risk groups, including older and obese subjects, could lead to a more a favored outcome in the cholesterol metabolism, CoQ~10~ and CoQ~10~ redox status.
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